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1. INTRODUCTION 
Human chorionic gonadotropin (hCG) is a 
glycoprotein hormone containing 30% car- 
bohydrate. It consists of two non-identical 
polypeptide chains, designated as a- and ,& 
subunits. The m-subunit is common among other 
glycoprotein hormones including LH, FSH and 
TSH, whereas the P-subunit dictates the specific 
hormonal activities. The assignment of P-subunit 
as the functional specific unit derives largely from 
the hybridization studies between the two subunits 
of interhormones and interspecies, in which the 
specific hormonal activity of such hybride always 
follows the P-subunit present. Studies based on 
chemical and enzymatical modifications of car- 
bohydrate moieties in hCG have revealed that the 
terminal sialic acid residues are important in pro- 
longing the plasma circulatory life of the hormone, 
and that successive xoglycosidase treatments of 
asialo-hCG reduce its ability to stimulate the pro- 
duction of CAMP and steroids in gonadal cells 
[l-5]. However, the role of the carbohydrate 
structures of each subunit in the essential hor- 
monal activities of hCG has not been investigated. 
We therefore addressed the following questions in 
an attempt to clarify the role of carbohydate 
moieties in the subunits: 
Abbreviations: (A) and (A-HF) desialylated and HF- 
deglycosylated modifications, respectively 
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(i) How does the modification of one subunit af- 
fect hormonal activity? 
(ii) Can the removal of galactose residues from 
the asialo-molecules regenerate the in vivo 
biological activity? 
(iii) Do the carbohydrate structures in CY- and ,&- 
subunits have a different role? 
Here, we present modifications of cr- and ,& 
subunits by desialylation with neuraminidase, and 
followed by treatment with anhydrous HF in the 
presence of anisole [6,7]. Four representative 
recombinants from modified and intact subunits 
were prepared. Evaluation of their biological ac- 
tivities has revealed that these recombinants were 
28-46% as active as the native hCG in a receptor 
binding assay. In an in vivo bioassay, the ,& 
modified recombinants were completely inactive 
whereas the a-modified recombinants preserve 2% 
[a(A):fl and 10% [cu(A-HF):,&j of the potency of 
hCG. Our results suggest that the carbohydrate 
structures in the P-subunit play a dominant role in 
the determination of in vivo biological activity. 
2. MATERIALS AND METHODS 
2.1. Hormone preparation 
Purified hCG (biological potency, 11600 
IU/mg) and its a- and &subunits were lot CR1 19 
which were obtained from the Center of Popula- 
tion Research, National Institute of Child Health 
and Human Development. The (Y- and P-subunit 
preparations contained < 0.2-0.05% of un- 
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dissociated and/or reassociated hCG as determin- 
ed by an in vivo bioassay. 
2.2, Carbohydrate modifications of hCGcv and 
hCGP subunits 
2.2.1. Desialylation 
The preparation of desialylated hCG subunits 
was carried out as follows. To a solution of each 
subunit (lot CR119, 50 mg) in 0.5 M potassium 
acetate (pH 6.0,2 ml) was added 0.55 ml of the en- 
zyme solution (neuraminidase, EC 3.2.1.18, from 
Clostridium perfringens, 92 pg of type X, Sigma, 
St. Louis) dissolved in the same buffer. The reac- 
tion mixture was incubated for 2 h at 37°C. 
Purification and removal of the enzyme were 
achieved by Sephadex G-100 gel chromatography 
using a series of 4 connecting columns (1.6 x 
343 cm) pre-equilibrated with 0.1 M NH4HC0s 
(pH 7.9). The fractions containing subunits were 
pooled and twice lyophilized to give a white 
powder (- 40 mg). Quantitative analysis of sialic 
acid as in [8] indicated the complete desialysation 
for both subunits. 
2.2.2. HF/Anisole treatment 
Desialylated subunits (20 mg each) obtained 
above were treated with anhydrous HF (10 ml) for 
1 h at 0°C in the presence of anisole (1 ml) as 
scavenger. Purification was carried out by the 
Sephadex G-100 gel chromatography as mentioned 
above for asialo-subunits. It yielded a white 
powder (-10 mg) after lyophilization. 
2.3. Recombinations of subunits 
Two subunits (3 mg each) were dissolved in 
0.1 M NH,HCOs (pH 7.9, 300 ~1). The mixture 
was incubated for 24 h at 4”C, and lyophilized in 
a high vacuum rotatory concentrator (Savant). The 
residue was dissolved in 0.1 M NH4HC0s (150 pl), 
and purified by HPLC using one TSK 2000SW and 
two 3000SW columns (Beckman Instrument, 
Calif.) in series. The fractions showing receptor 
binding activity were pooled and twice lyphilized to 
yield 3-4 mg of each recombinant. 
2.4. Bioassays 
Receptor binding activity was determined using 
a rat testis homogenate and 1251-labeled hCG (lot 
CR121) as tracer [9]. Statistical analyses were per- 
formed by the computer program in [lo]. 
The biological activity of hCG recombinants was 
evaluated by the uterine weight assay employing 
20-21-day-old female Holtzman rats. After sub- 
cutaneous injections of test solution (0.5 ml) in 
0.05 M phosphate-O. 1 M NaCl buffer (pH 7.4) for 
3 consecutive days, uteri were excised and weighed 
on the fourth day. The potency was calculated as 
in [ll]. 
2.5. Analytical methods 
The amino acid analyses were carried out by a 
Beckman Model 121MB analyzer after hydrolyses 
of the samples in constant-boiling HCl (24 h, 
1lO’C). Glucosamine and galactosamine were also 
determined by the amino acid analyzer after 
hydrolysis in 3 M HCl at 100°C for 3 h. Neutral 
sugars (i.e., mannose, galactose and fucose) were 
determined by the procedure in [12], and sialic acid 
as in [8]. 
3. RESULTS 
Desialylation of these subunits by neuraminidase 
treatment followed by Sephadex G-100 chromato- 
graphy yielded preparations of purified asialo- 
hCGcv and asialo-hCGP. Table 1 shows that both 
asialo-subunits were completely free of sialic acid. 
Further deglycosylation was accomplished by the 
HF/anisole treatment. After purification by Sepha- 
dex G-100 gel chromatography, deglycosylated 
Table 1 
Monosaccharide compositions of the modified hCG 
subunits 
Sugar hCGa hCGP 
Asialo Asialo-HF Asialo Asialo-HF 
NeuNAc 0 0 (0) 0 0 (0) 
Gal 3.0 0 (0) 6.3 0 (0) 
Man 5.6 1.6 (29) 5.2 1.5 (29) 
Fuc - _ 1.2 0 (0) 
GlcNAc 7.3 3.0 (41) 5.6 2.6 (46) 
GalNAc - _ 2.8 2.1 (75) 
Values are expressed as mol monosaccharide/mol pro- 
tein, and those in parentheses represent % of monosac- 
charide remaining after the HF-treatment 
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hCGa and hCG,8 were obtained. Table 1 shows 
their monosaccharide compositions. Based on the 
structure of carbohydrate moieties in native hCG, 
the HF treatment cleaves predominantly the sac- 
charide linkages at the mannose residues of the 
Asn-linked moiety and at the galactose residue of 
the Ser-linked moiety. The absence of galactose in 
both subunits and fucose in the P-subunit after the 
HF-treatment is worth noting. Furthermore, no 
difference in amino acid compositions was de- 
tected between the native and desialylated or degly- 
cosylated molecules of two subunits. 
Four recombinants [&A) :fl, cu(A-HF) :,&, 
a$(A) and a:,&(A-HF)] were prepared and 
purified by the gel-HPLC chromatography. The 
representative chromatogram is shown in fig. 1. 
All recombinants howed a symmetrical peak and 
were well-separated from the excess a-subunits. In 
order to minimize any possible contaminants of the 
non-recombined subunits, only these earlier 
eluants exhibiting high receptor binding activity 
were collected. The amino acid analyses of all 
recombinants revealed that their compositions 
were in close agreement with the expected 
stoichiometry of the unmodified hCG. 
m 
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Fig. 1. High-performance gel chromatography of hCG 
and recombinants a(A)-fl and cu:,&(A-HF). Ordinate is 
absorption at 225 nm. I/o and Vl are void and total 
volume of columns, respectively. Elution volume (ml) 
for each component is indicated on the top of peak. 
Injected solution was -2 mg protein/ml. 
Table 2 
Biological activity of hCG recombinants 
hCG and 
analogues 
Relative potency 
Receptor binding Uterine weight 
assay assay 
hCG (lot CR119) 1.0 1.0 
a(A):P 0.36 + 0.04 0.019 f 0.007 
LU(A-HF) : p 0.28 + 0.03 0.094 * 0.010 
(Y : P(A) 0.46 Y!Z 0.05 nd. 
(Y : ,&(A-HF) 0.17 f 0.02 n.d. 
Values are expressed relative to mol hCG f SE n.d., not 
detectable ata total dose of 3pg/rat 
Table 2 shows the radioligand-receptor binding 
activity of 4 recombinants. It is obvious that all 
recombinants displayed lower activity than hCG in 
competing with i251-hCG for binding to the rat 
testis homogenate. Desialylation of either LY- or ,8- 
subunit in hCG reduced the binding potency to the 
extent of 36-46%. The HF treatment reduced fur- 
ther their potencies. The decreased binding activity 
of a:fi(A-HF), compared with other recom- 
binants, is most obvious. It may suggest that 
deglycosylation of the P-subunit causes a signifi- 
cant inactivation of the hormone binding process. 
In the in vivo immature rat uterine weight assay, 
intact hCG (lot CR119) doubled uterine weight at 
50 ng/rat. In parallel assays, both a:,&(A) and 
cy :,8(A-HF) did not display any significant 
responses at 3 pug/rat. In contrast, the a(A):,& 
species exhibited measurable activity at the same 
dose level, which was equivalent o a potency of 20 
IU/mg or 2% of hCG (table 2). Replacement of 
a(A) by further deglycosylated a(A-HF) to form 
a(A-HF) :,8 increased the bioactivity 5-fold over 
that of au(A) :,8, although their receptor binding ac- 
tivities were of the same order. 
Collectively, these results indicate that the P- 
subunit does not tolerate modifications on the car- 
bohydrate moieties whereas the a-subunit is 
relatively inert in maintaining the biological ac- 
tivities, when the subunit recombines with the in- 
tact counterpart. Furthermore, it is intriguing that 
the removal of galactose residues from the a- 
subunit causes the increase in the in vivo biological 
activity. 
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4. DISCUSSION 
It has been recognized that asialo-hCG possesses 
insignificant in vivo biological activity [3,4]. On 
the other hand, it largely retains in vitro activities 
of receptor binding, CAMP and testosterone 
stimulations [1,2]. The cause of in vivo inactiva- 
tion has been correlated with the marked decrease 
in plasma half-life due to the exposure of galactose 
residues at the termini of carbohydrate chains. Ac- 
cordingly, a galactose-recognizing receptor in liver 
parenchymal cells quickly binds to asialo-hCG for 
metabolism and prevents the modified hormone 
from reaching its target organs [ 141. The additional 
removal of galactose from asialo-hCG by fl- 
galactosidase did not affect the receptor binding 
properties, but reduced stimulation of CAMP for- 
mation [4]. Similarly, the HF-deglycosylated hCG 
displayed higher testis receptor binding activity but 
at least lOO-fold lower stimulation of CAMP and 
testosterone production in Leydig cell than those 
of the intact hCG [7]. The deglycosylatd hCG ex- 
hibited no in vivo biological activity as a result of 
modification in the carbohydrate moieties on both 
(Y- and &subunits. Modifications of the galactose 
residues of asialo-hCG prolonged plasma half-life 
from 0.5 min to lo-17 min (49 min for intact 
hCG) in [15]. The in vivo ovarian uptake of those 
derivatives was substantially increased over that of 
asialo-hCG. However, they neither evaluated the in 
vivo biological activity nor directed at the question 
of how the modification of each subunit in hCG 
can affect the overall hormonal activity. 
We have taken several precautions in the purifi- 
cation of both modified subunits and their recom- 
binants. The recombinants were examined by 
HPLC, receptor binding activity and amino acid 
composition to ensure that they contained no free 
subunit. From the result of receptor binding ex- 
periments, all 4 recombinations exhibited 17-46070 
activity of hCG. The low activities of both a(A):,& 
and (Y@(A) appear to be in contradiction to the 
previous finding that asialo-hCG is as active as 
hCG in both receptor binding and steroidogenic 
activities in vitro [1,2]. However, the dissociated 
and subsequently re-associated hormone has dis- 
played reduced in vivo biological activity as com- 
pared to that of the original hormone [ 131. In addi- 
tion, it is not yet known whether the reassociated 
hormone with both asialo-subunits will be as active 
as the asialo-hCG in vitro. Nonetheless, the com- 
plete absence of in vivo biological activity in 
(r :,&A) and cr :P(A-HF) is obvious. On the other 
hand, (U(A):@ and a(A-HF):,8 displayed some in 
vivo biological activity despite that all 4 recombi- 
nants showed nearly the same order of binding 
activity. Collectively, desialylation reduced signifi- 
cantly the in vivo biological activity of recombi- 
nants. The complete absence of activity in CY $(A) 
and residual activity in a(A) :,8 indicates that the P- 
subunit is more sensitive to desialylation-related re- 
duction of biological activity. 
The increased activity of a(A-HF):P, as com- 
pared to a(A):,&, reflects the fact that the absence 
of terminal galactose residues may cause the hor- 
mone to be relatively inert for the uptake by galac- 
tose receptor in liver. Unlike the case of a(A) :,8 vs 
@(A-HF) :p, LY :,&(A-HF) failed to regenerate the in 
vivo activity. These data further suggest hat im- 
portance of carbohydrate structures differs bet- 
ween the LY- and P-subunits, and that the &subunit 
plays a dominant role in determining the hormonal 
activity of hCG. Perhaps the carbohydrate struc- 
ture in the P-subunit carries the essential functional 
message necessary to convey the hormonal signal 
to the target cells. 
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